Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Microvasc Res. 2010 Oct 23;81(1):44–51. doi: 10.1016/j.mvr.2010.10.003

Fig. 1.

Fig. 1

Patent tumor blood vessels. KHT sarcoma-bearing mice were treated with 25 mg/kg of either OXi4503 (cis-isomer of CA1P) or trans-CA1P. Tumors were harvested and patent blood vessels quantified based on Hoechst 33342 staining at various times after drug exposure. *, p<0.001 versus controls.